Cuvitru is an immunoglobulin (also known as antibody) that's used to treat primary immunodeficiency (PI) in adults and children ages 2 years and older. It's given as an injection under the skin using an infusion pump. The infusion takes 2 hours on average, but how long it takes depends on your dose and how well you tolerate the medication. Side effects include headache, nausea, and infusion-related reactions (e.g., redness, itching, pain).
Cuvitru is a replacement for immunoglobulin G (IgG). IgG is a type of antibody that the immune system naturally makes to help fight off viruses and bacteria to prevent infections. But people with primary immunodeficiency don't have enough IgG that works properly, which raises their risk of infections.
The exact way Cuvitru works isn't completely known. But it's thought to work by boosting your immune system to help prevent infections.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
How to use Cuvitru at home:
In general, the average infusion time will be about 2 hours. But the infusion time will depend on your dose, your infusion rate (how fast you're getting the medication through the infusion pump), how many infusion sites you're using, and how well you tolerate the infusion. When you first start treatment, you'll typically start at a low dose that's given at a slow infusion rate so that your body can get used to the infusions. Then, your provider will gradually raise the dose and infusion rate as long as your body doesn't react poorly to it. This means that your infusions might take longer at first. Speak to your provider so you know what to expect.
It's possible. Ask your provider about using Cuvitru at home. Your provider will probably administer your doses at the clinic or infusion center when you first start using the medication. Depending on how comfortable you are, your provider might train you on how to give yourself the injections or your provider might decide it's better for you to get your doses at a clinic or infusion center.
Weight gain wasn't a reported side effect from people who took Cuvitru during clinical studies. Some IgG brand-name products contain sugar, which can potentially contribute to weight gain, but Cuvitru doesn't have any sugar in it. IgG products like Cuvitru generally require a lot of fluid per dose. This can cause temporary weight gain due to too much fluid. Contact your provider if you notice sudden weight gain.
Since Cuvitru can cause side effects in different parts of your body that you might not feel, your provider will order some lab tests for you to get before you start this medication and also regularly throughout treatment. Some tests check your kidney and lung health, your blood cell count, and your blood protein and triglyceride (fat) levels. Ask your provider if you have any questions about the lab tests you need to get and your test results.
You can still get most vaccines, including certain forms of the flu shot, while you're taking Cuvitru. But you shouldn't get live vaccines because it's not known whether they work well while you're getting treated with this medication. Some live vaccines include FluMist Quadrivalent (live attenuated influenza vaccine) nasal spray and MMR (measles, mumps and rubella vaccine). Before starting Cuvitru, talk with your provider to make sure you're up to date with all of your recommended vaccines. Once you've started treatment, let your provider know that you're taking Cuvitru before you get any vaccines. Your providers can double check whether the vaccine is safe for you to get.
Cuvitru can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Cuvitru can raise your risk of getting blood clots in various parts of your body. Anyone can get a blood clot during treatment, but having certain factors can raise your risk even more. Symptoms of a blood clot might be different depending on the location of the clot. They can include swelling, warmth, or tenderness in the legs. But more seriously, clots can lead to breathing problems, heart problems, or stroke. Symptoms of more serious blood clots include chest pain, difficulty breathing, or weakness on one side of the body. Call 911 if you have any of these symptoms because this is a medical emergency.
Your provider will monitor you closely for symptoms of blood clots while you're getting treated with Cuvitru. If you're at risk for blood clots, your provider might adjust your dose and infusion rate. Make sure you're well-hydrated before each Cuvitru injection to help prevent blood clots from happening.
Serious allergic reactions to Cuvitru are possible, including life-threatening reactions like anaphylaxis (e.g., closing of the throat). Stop the Cuvitru infusion and get medical attention right away if you notice dizziness, nausea, a choking sensation, difficulty breathing, swelling around your eyes, or swelling of the lips or tongue after taking the medication.
Human immune globulin products like Cuvitru can cause severe and even fatal kidney problems. Your risk is higher if you have certain factors, like older age, diabetes, or are taking medications that can harm the kidneys. Your provider will order lab tests to check your kidney health before and during treatment with Cuvitru. If your kidney health worsens, your provider might stop your treatment. Tell your provider if you develop any signs or symptoms of kidney failure, including changes in your need to urinate, tiredness, dry and itchy skin, low appetite, and muscle cramps.
Although rare, some people who used Cuvitru developed swelling or inflammation in the brain (aseptic meningitis). Sometimes, symptoms can start within several hours to two days after the infusion. It typically goes away within several days after stopping treatment. Call your provider if you have symptoms of meningitis, like severe headache, neck stiffness, sleepiness, fever, sensitivity to light, painful eye movements, nausea, or vomiting.
Cuvitru can cause your body to rapidly destroy your red blood cells, which can lead to anemia. Your provider might check your blood cell counts during treatment to make sure your red blood cell count doesn't drop too low. Contact your provider if you have symptoms of anemia, such as tiredness, dizziness, and weakness.
Human immune globulin products like Cuvitru can sometimes cause a condition called transfusion-related acute lung injury (TRALI). This condition happens when fluid backs up in your lungs. Symptoms of the lung problem typically appear within 1 to 6 hours after the infusion. Symptoms include severe breathing problems, chest pain or tightness, a racing heartbeat, and fever. Tell your provider right away if you have any of these symptoms so you can get treated.
Because Cuvitru is made from human blood products, there's a risk that it might contain viruses or other germs that can make you sick. But your risk of infection is low since the donors of these blood products are carefully screened. Also, there are high manufacturing standards put into place to make sure the germs are killed or removed. To prevent serious infections in the rare case that your doses of Cuvitru are affected, let your provider know right away if you start to feel sick or have symptoms such as feeling confused and anxious or having trouble maintaining your balance.
Cuvitru is typically given as an injection under the skin using an infusion pump. How often you need injections ranges from once per day to once every 2 weeks.
Your dose depends on your body weight, previous dose of immune globulin therapy, and lab results. Your provider will calculate and adjust your dose, your infusion rate, and how often you need infusions based on how well you respond to the medication.
Your provider might also change your dose if you've been exposed to measles and if you're at risk of measles exposure (e.g., traveling to certain places).
Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Cuvitru will not be safe for you to take.
Conditions where your immune system is missing or not working like it should: